| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.07 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.08 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |